1. Home
  2. ATYR vs FLYX Comparison

ATYR vs FLYX Comparison

Compare ATYR & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • FLYX
  • Stock Information
  • Founded
  • ATYR 2005
  • FLYX 2015
  • Country
  • ATYR United States
  • FLYX United States
  • Employees
  • ATYR N/A
  • FLYX N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • FLYX Blank Checks
  • Sector
  • ATYR Health Care
  • FLYX Finance
  • Exchange
  • ATYR Nasdaq
  • FLYX Nasdaq
  • Market Cap
  • ATYR 105.8M
  • FLYX 102.4M
  • IPO Year
  • ATYR 2015
  • FLYX N/A
  • Fundamental
  • Price
  • ATYR $0.93
  • FLYX $4.23
  • Analyst Decision
  • ATYR Buy
  • FLYX
  • Analyst Count
  • ATYR 6
  • FLYX 0
  • Target Price
  • ATYR $8.88
  • FLYX N/A
  • AVG Volume (30 Days)
  • ATYR 23.5M
  • FLYX 55.4K
  • Earning Date
  • ATYR 11-06-2025
  • FLYX 11-13-2025
  • Dividend Yield
  • ATYR N/A
  • FLYX N/A
  • EPS Growth
  • ATYR N/A
  • FLYX N/A
  • EPS
  • ATYR N/A
  • FLYX N/A
  • Revenue
  • ATYR N/A
  • FLYX $347,746,000.00
  • Revenue This Year
  • ATYR $420.85
  • FLYX $28.47
  • Revenue Next Year
  • ATYR $1,919.44
  • FLYX $22.44
  • P/E Ratio
  • ATYR N/A
  • FLYX N/A
  • Revenue Growth
  • ATYR N/A
  • FLYX 17.09
  • 52 Week Low
  • ATYR $0.68
  • FLYX $1.79
  • 52 Week High
  • ATYR $7.29
  • FLYX $6.90
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 27.94
  • FLYX 48.48
  • Support Level
  • ATYR $0.68
  • FLYX $3.87
  • Resistance Level
  • ATYR $0.86
  • FLYX $4.65
  • Average True Range (ATR)
  • ATYR 0.08
  • FLYX 0.51
  • MACD
  • ATYR 0.13
  • FLYX -0.14
  • Stochastic Oscillator
  • ATYR 69.00
  • FLYX 22.18

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

Share on Social Networks: